Literature DB >> 17345091

The effects of the phosphodiesterase type V inhibitor sildenafil on human and bovine retinal function in vitro.

Matthias Lüke1, Peter Szurman, Toni Schneider, Christoph Lüke.   

Abstract

BACKGROUND: After the ingestion of sildenafil (Viagra), visual adverse events have been reported, possibly caused by an inhibition of the phototransduction cascade by sildenafil via phosphodiesterase (PDE 6). Therefore, we investigated the effects of sildenafil on photoreceptors and postsynaptic neurons of human and bovine retinas using the isolated superfused vertebrate retina technique.
METHODS: Human and bovine retina preparations were perfused with an oxygen preequilibrated standard solution. The electroretinogram (ERG) was recorded using Ag/AgCl electrodes. After recording stable ERG amplitudes, sildenafil was added to the solution for 45 min. Thereupon, the preparations were reperfused with standard solution for 240 min.
RESULTS: Following the application of sildenafil (3 microMol/l), the b-wave amplitude of bovine and human preparations was reduced continuously and disappeared completely. After reperfusion with the standard solution for 4 h, the b-wave amplitude did not recover completely. Using the same sildenafil concentration (3 microMol/l), the a-wave amplitude of the human retina was not totally abolished, but reduced to 21% of the initial amplitude and remained reduced at washout. For all retinal preparations, the implicit time of the ERG amplitudes remained significantly extended at the end of the washout.
CONCLUSIONS: Strong similarities were detected in the drug-induced changes of the ERG when comparing human and bovine retinas. The results suggest that sildenafil impairs retinal function at not only the level of the photoreceptors, but it also affects the neuronal network of the inner retina at concentrations of approximately 30-fold higher than at therapeutic plasma concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17345091     DOI: 10.1007/s00417-007-0562-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  16 in total

1.  cGMP-dependent kinase regulates response sensitivity of the mouse on bipolar cell.

Authors:  Josefin Snellman; Scott Nawy
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

2.  Ocular safety of Viagra, (sildenafil citrate).

Authors:  A M Laties; F T Fraunfelder
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  Glutamate receptors of rod bipolar cells are linked to a cyclic GMP cascade via a G-protein.

Authors:  R A Shiells; G Falk
Journal:  Proc Biol Sci       Date:  1990-11-22       Impact factor: 5.349

4.  Retinal side-effects of sildenafil.

Authors:  M A Vobig; T Klotz; M Staak; K U Bartz-Schmidt; U Engelmann; P Walter
Journal:  Lancet       Date:  1999-01-30       Impact factor: 79.321

5.  Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase.

Authors:  D Behn; M J Potter
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

6.  The influence of phosphodiesterase inhibitors on ERG and optic nerve response of the cat.

Authors:  T Schneider; E Zrenner
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-09       Impact factor: 4.799

7.  The effect of aspartate on the electroretinogram of the vertebrate retina.

Authors:  I Hanawa; T Tateishi
Journal:  Experientia       Date:  1970-12-15

8.  Anterior ischemic optic neuropathy associated with viagra.

Authors:  A V Cunningham; K H Smith
Journal:  J Neuroophthalmol       Date:  2001-03       Impact factor: 3.042

9.  Mutations in the PDE6B gene in autosomal recessive retinitis pigmentosa.

Authors:  M Danciger; J Blaney; Y Q Gao; D Y Zhao; J R Heckenlively; S G Jacobson; D B Farber
Journal:  Genomics       Date:  1995-11-01       Impact factor: 5.736

10.  Effects of IBMX on the ERG of the isolated perfused cat eye.

Authors:  M A Sandberg; B S Pawlyk; W G Crane; S Y Schmidt; E L Berson
Journal:  Vision Res       Date:  1987       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.